The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
92602553 9260255 3 F 2012 20160729 20130429 20160805 EXP GR-AMGEN-GRCSP2013028516 AMGEN 72.00 YR E F Y 77.00000 KG 20160805 OT GR GR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
92602553 9260255 1 PS PROLIA DENOSUMAB 1 Subcutaneous 1 DF, Q6MO Y 125320 1 DF SOLUTION FOR INJECTION
92602553 9260255 2 C CALCIORAL 2 UNK 0
92602553 9260255 3 C THYROXINE LEVOTHYROXINE 1 0
92602553 9260255 4 C ONE ALPHA ALFACALCIDOL 1 UNK 0
92602553 9260255 5 C TENORMIN ATENOLOL 1 25 MG, UNK, DOSE INCREASED TO 37 MG 0 25 MG QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
92602553 9260255 1 Osteoporosis
92602553 9260255 3 Autoimmune thyroiditis
92602553 9260255 5 Heart rate abnormal

Outcome of event

Event ID CASEID OUTC COD
92602553 9260255 OT
92602553 9260255 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
92602553 9260255 Acute myocardial infarction
92602553 9260255 Alopecia
92602553 9260255 Anxiety
92602553 9260255 Arrhythmia
92602553 9260255 Arthralgia
92602553 9260255 Atrial fibrillation
92602553 9260255 Blood pressure increased
92602553 9260255 Bowel movement irregularity
92602553 9260255 Chest pain
92602553 9260255 Cough
92602553 9260255 Decreased appetite
92602553 9260255 Depressed mood
92602553 9260255 Diarrhoea
92602553 9260255 Eosinophil percentage increased
92602553 9260255 Epistaxis
92602553 9260255 Extrasystoles
92602553 9260255 Fatigue
92602553 9260255 Fibrin D dimer increased
92602553 9260255 Hypertensive crisis
92602553 9260255 Injection site pain
92602553 9260255 Insomnia
92602553 9260255 Irritability
92602553 9260255 Malaise
92602553 9260255 Mental disorder
92602553 9260255 Oedema
92602553 9260255 Oedema peripheral
92602553 9260255 Pain
92602553 9260255 Pain in extremity
92602553 9260255 Panic attack
92602553 9260255 Peripheral venous disease
92602553 9260255 Pulmonary embolism
92602553 9260255 Pyrexia
92602553 9260255 Tachycardia
92602553 9260255 Vertigo
92602553 9260255 Xanthelasma

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
92602553 9260255 1 20120603 201212 0